Company Overview

Sunrest Lifescience Limited was originally incorporated as "Sunrest Lifescience Private Limited" on October 30, 2017, by the Registrar of Companies, Ahmedabad, Gujarat. It was subsequently converted into a Public Limited Company and renamed "Sunrest Lifescience Limited" with a fresh Certificate of Incorporation issued on March 21, 2023. The company is listed and trades on the NSE stock exchange under the symbol SUNREST, operating within the Health Care sector and Pharmaceuticals sub-sector.

Business Operations and Product Portfolio

Sunrest Lifescience Limited is engaged in the trading, wholesale, and retail of pharmaceutical products within the domestic Indian market. The company specializes in marketing over-the-counter (OTC) generic pharmaceutical products manufactured by third-party manufacturers. Its operations span across various Indian states, including Maharashtra, Gujarat, Madhya Pradesh, Orissa, and Rajasthan.

The company offers a comprehensive range of pharmaceutical and healthcare products, covering categories such as:

- Anti-bacterials

- Antibiotics

- Anti-amoebics

- Anti-fungals

- Analgesics

- Neuropathy medications

- Anti-hypertension drugs

- Anti-inflammatory products

- Anti-ulcerants

- Anti-cold and anti-cough medicines

- Anti-allergics

- Nutritionals

- Ayurvedic products

- Cosmetics

These products are available in diverse forms including tablets, capsules, soft gels, syrup, dry-syrups, injections, cream-ointments, powders, gel, mouthwash, solutions, suspensions, dry powders, and toothpaste. Sunrest Lifescience distributes its products through a well-established network of distributors and resellers.

Financial Performance and Key Metrics

As of the latest available data:

- Revenue: ₹29.5 Crores

- Profit: ₹0.23 Crores

- Revenue (2023): ₹24.67 Crores

- Net Worth (2023): ₹3.11 Crores

The company has demonstrated consistent revenue generation and reported profits, but it does not currently pay dividends.

Key Financial Ratios (as of May 6, 2025):

- P/E Ratio: 96.32

- P/B Ratio: 1.54 (with variations reported at 0.65)

- Earnings Per Share (TTM): 4.67

- Return on Equity (ROE): 2.66%

- Return on Capital Employed (ROCE): 6.33%

Market Capitalization and Share Price Performance

- Market Capitalization: ₹21.91 Crores (as of May 6, 2025)

- Share Price Performance (Last 6 Months): Decreased by 9.89%

- Share Price Performance (Last 1 Year): Decreased by 27.07%

- 52-Week High: ₹79.00

- 52-Week Low: ₹44.60

Shareholding Pattern and Corporate Structure

- Promoter Holding: 69.9%

- Key Management:

- Juhi Sawajani (Chairman)

- Nishi B Shah (Company Secretary)

- Nikhilkumar Yashvntlal Thakkar (Managing Director)

- Amitbhai Shambhulal Thakkar (Whole-Time Director)

The company employs 140 professionals.

Operational Challenges and Working Capital

The company faces specific operational challenges:

- High Debtors: Average debtor collection period is 186 days.

- Working Capital: Working capital days have significantly increased from 120 days to 244 days, indicating potential cash flow management issues that investors should monitor closely.

Corporate Governance and Recent Developments

- Latest AGM: September 28, 2024

- Balance Sheet Filing: March 31, 2024

- Company Secretary Appointment: Neelam Gattani appointed on March 29, 2025.

- Regulatory Updates: Confirmed non-applicability of SEBI large corporate debt issuance rules as of March 31, 2025. Board meetings are scheduled to consider audited financial results.

Capital Structure and Business Location

- Authorized Capital: ₹14.00 Crores

- Paid-up Capital: ₹4.29 Crores

- Headquarters: Ff-41 Ajay Tenament-6 Near Canal Near Ritanagar Bus Stand Vastral Road, Ahmedabad, Gujarat, 382415.

Sunrest Lifescience Ltd operates as a focused pharmaceutical trading company with an established market presence across several Indian states. While the company demonstrates consistent operational performance in the competitive pharmaceutical sector, investors should carefully consider the working capital challenges and recent stock price performance trends when making investment decisions.